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A B S T R A C T
The comet assay is a well-accepted biomonitoring tool to examine the effect of dietary, lifestyle,
environmental and occupational exposure on levels of DNA damage in human cells. With such a wide
range of determinants for DNA damage levels, it becomes challenging to deal with confounding and
certain factors are inter-related (e.g. poor nutritional intake may correlate with smoking status). This
review describes the effect of intrinsic (i.e. sex, age, tobacco smoking, occupational exposure and obesity)
and extrinsic (season, environmental exposures, diet, physical activity and alcohol consumption) factors
on the level of DNA damage measured by the standard or enzyme-modiﬁed comet assay. Although each
factor inﬂuences at least one comet assay endpoint, the collective evidence does not indicate single
factors have a large impact. Thus, controlling for confounding may be necessary in a biomonitoring study,
but none of the factors is strong enough to be regarded a priori as a confounder. Controlling for
confounding in the comet assay requires a case-by-case approach. Inter-laboratory variation in levels of
DNA damage and to some extent also reproducibility in biomonitoring studies are issues that have
haunted the users of the comet assay for years. Procedures to collect specimens, and their storage, are not
standardized. Likewise, statistical issues related to both sample-size calculation (before sampling of
specimens) and statistical analysis of the results vary between studies. This review gives guidance to
statistical analysis of the typically complex exposure, co-variate, and effect relationships in human
biomonitoring studies.
© 2019 Elsevier B.V. All rights reserved.
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Molecular epidemiology is based on the use of molecular
biomarkers to identify or quantify disease effects or risk in
epidemiological studies. Molecular epidemiology applied to
humans has the advantage of being directly relevant, unlike
animal or other experimental models that require extrapolation to
humans. In epidemiological studies, biomarkers can be used in
combination with health data to demonstrate an association
between the body burden of pollutants and their health effects, or
simply to test other research hypotheses [1,2].
Biomarkers are typically measured in samples that can be
obtained (relatively) non-invasively, which generally means blood
or urine. DNA damage is recognized as a useful biomarker, by virtue
of its role in carcinogenesis. Many lesions occur in the DNA of every
cell each day, inﬂicted by natural or artiﬁcial exogenous radiation
sources or genotoxic chemicals, or by endogenous exposure to e.g.
reactive oxygen species, or as a result of errors in replication. But it
should be borne in mind that almost all DNA damage is repaired,
and that even if damage is present when DNA is replicated, it
doesn’t necessarily cause mutations. DNA damage should be
regarded as a marker of exposure to DNA-damaging agents, and in
that sense it reﬂects disease risk, but whether it can be seen as a
predictive marker of individual cancer risk is debatable, in the
absence of compelling evidence.
The comet assay is the most popular method for measuring
DNA damage in human cells. Essentially it measures DNA breaks,
through their ability to relax the supercoiling of DNA loops which
can then extend under (alkaline) electrophoresis to form comet-
like images; the relative intensity of tail DNA ﬂuorescence
indicates the frequency of breaks (Fig. 1). An additional step can
be introduced, digesting the DNA with a lesion-speciﬁc enzyme, so
that – for instance – oxidised bases are converted to breaks and thecomet tail intensity increases. This modiﬁcation is particularly
useful in biomonitoring, as oxidative stress – and consequent DNA
oxidation – is a feature of various kinds of exposure and many
human diseases.
The aim of this article is to describe the key issues that are
relevant in a biomonitoring study in which the comet assay is
applied to measure DNA damage. We describe how different co-
variates may affect the outcome of the study. Some of the factors
have been speciﬁcally assessed in systematic reviews, while others
have not yet been assessed thoroughly. Some technical aspects
related speciﬁcally to biomonitoring are also covered, such as
sampling and storing of specimens, as well as statistical and ethical
issues that should be addressed before and after the biomonitoring
study. However, technical issues related speciﬁcally to variability
in assay conditions and efforts to produce standard procedures
have been reviewed elsewhere [4]. Inter-laboratory variation in
DNA damage levels has been described since the early 2000s
through ring-trials involving multiple laboratories [5–7]. Later
ring-trials have shown reductions in inter-laboratory variation in
DNA damage levels on cryopreserved cells by using standardiza-
tion with reference standards and standardized comet assay
procedures, although some variation persists even after such
means of standardization [8–13].
In the context of the present review, exposure may refer to
potentially hazardous agents of either physical (e.g. radiation) or
chemical nature. Alternatively, an exposure may be positive in
terms of health beneﬁts - for example, certain dietary items and
habits such as regular exercise. The present review encompasses
studies that have assessed the effect of exposure on DNA damage.
In this type of study, exposure (e.g. to a chemical agent) is the
predictor and the level of DNA damage is the outcome. By design,
the case-control study selects ﬁrst the cases (and a matched
control group) and then assesses the exposure. In that sense, the
Fig.1. Scheme of the comet assay. Different parameters are used to describe each comet, for example % DNA in tail, tail length or tail moment [3]. The mean or the median of at
least 100 comets is normally used to describe each sample.
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Fig. 2. Effect of age and sex on levels of DNA damage. As endogenous factors, age
and sex may be regarded as classic confounders, i.e. they are associated with both
the exposure and level of DNA damage (A). They may also affect the level of DNA
damage through the exposure (B). As effect mediators, age and sex are observed to
have an effect on DNA damage (e.g. in different strata of men and women, or old and
young subjects), but this is mediated by underlying differences in exposures or life-
style factors (C). Solid arrows refer to direct (“causal”) relationships, whereas
stippled arrows are associations (“perceived relationships”). The non-modiﬁable
extrinsic factors are ubiquitous exposures (i.e. affecting whole populations rather
than being relevant for certain individuals). These may be obtained by sampling on
different days or in different seasons (i.e. seasonal variation).
4 A. Azqueta et al. / Mutation Research 783 (2020) 108288level of DNA damage is the predictor, whereas the disease status is
the outcome.
2. Selection of subjects
In human exposure studies, the predictor is either dichoto-
mized into no exposure versus exposure (or low versus high
exposure) or treated as a continuous variable. The outcome
variable is usually treated as a continuous factor, although data
reduction to categorical scale may occur in certain studies. The
typical biomonitoring study assesses the effect of a certain
predictor (here “exposure”) on the outcome (here “DNA damage”).
The trick is to obtain a gradient in the exposure, while at the same
time avoiding selection of other factors that can inﬂuence the
exposure-outcome relationship. This kind of disproportionate
selection of certain factors in exposure groups is called confound-
ing only if the factor is associated with both the predictor and the
outcome. As the confounder per se is an independent risk factor for
the outcome, it can be used ingeniously to gain better under-
standing of the complex relationship between exposure and
outcome by for instance designing studies that utilize the
information to test for interactions between the exposure and
susceptibility factors. For example, age, sex and smoking are
typically regarded as confounders, but a study can be carefully
designed to assess the effect modiﬁcation due to these factors by
demonstrating that a certain exposure is only increasing the level
of DNA damage in e.g. men, old people or smokers.
2.1. Confounders, effect modiﬁers and effect mediators in human
biomonitoring studies
In molecular epidemiology, confounders, effect modiﬁers and
effect mediators are factors that are used as co-variates in the
statistical models. Below, age and sex are used as examples of
factors that can be confounders, effect modiﬁers and effect
mediators (further discussion of these variables in statistical
modelling is provided in section 6. Statistical analysis). There is a
wealth of information on effects of age and sex in biomonitoring
studies because this information is frequently reported in the
description of the subjects. However, only a few studies have been
designed speciﬁcally to test effects of age and sex on DNA damage
measured with the comet assay.
Fig. 2 describes different ways that effects of age and sex can be
(or have been) assessed in study designs and statistical analyses. In
these examples age and sex are regarded as endogenous factors,
whereas “exposure” is an external factor. Age and sex may be
regarded as confounders, i.e. they are associated with both the
exposure (i.e. predictor) and level of DNA damage (i.e. outcome). As
confounders, age and sex are associated with exposure if the
selection of subjects according to the exposure status has also
introduced an unequal balance in the age and sex distribution (e.g.
those who are exposed are also older or predominantly males).
This implies that information on age and sex is “irrelevant” in the
sense that the statistical analysis adjusts for the effect of the
confounders. It should be noted that control for confounding is a
statistical solution to a study design problem and the confounder is
considered a priori to have an effect on the association between
exposure and level of DNA damage. Other ways to prevent the
effect of confounders are randomisation, restriction or matching of
subjects. Age and sex may also be regarded as effect modiﬁers, i.e.
the effect of an exposure will differ in strata of the dataset due to
biological reasons (men and women, or old and young subjects,
may have different responses to exposures). This is demonstrated
by statistical analysis showing an interaction between the
exposure and the modiﬁer. Finally, the effects of age and sex
may be mediated through exposures or life-style factors. In thiscase age and sex do not have a direct effect on the outcome (i.e.
DNA damage). The apparent effect of age (and sex) on the outcome
is explained by intermediate steps in the pathway. In this case
(Fig. 2C), it is incorrect to consider age and sex as confounders as
they are not independent risk factors for the outcome.
2.2. Types of factors that inﬂuence the level of DNA damage in humans
The planning of human biomonitoring studies entails a careful
assessment of possible contributing factors to the level of DNA
damage as well as within-group variation. This pertains not only to
dealing with confounders (i.e. avoiding a systematic error), but also
to random factors that might give rise to outliers in the results. The
latter may be difﬁcult to control as it could compete with a smooth
selection of subjects or matching criteria between groups of
exposed and controls. Table 1 describes the four different types of
factors, which are described in further detail in the subsequent
sections.
2.2.1. Intrinsic and non-modiﬁable factors
Sex and age are factors that subjects cannot change in the same
way that dietary habits, physical activity or speciﬁc chemical
exposures can be altered. The impact of age and sex on levels of
DNA damage is well-known as illustrated by the several
biomonitoring studies that restrict the inclusion of subjects to
speciﬁc age groups or sex. The present review encompasses only
studies that have assessed age and sex differences in DNA damage
levels as a primary purpose of the investigation. These are
predominantly cross-sectional studies. A detailed analysis of the
effect of age and sex on DNA damage levels measured with the
comet assay is reported elsewhere [14]. Various types of exposure
studies have not been included because selection or matching of
subjects in the reference group may have occurred. Cross-sectional
studies are suitable for assessment of sex-speciﬁc differences in
DNA damage levels, whereas they are not ideal for age-dependent
differences because it is not possible to assess whether DNA
Table 1
Types of factors that can affect the level of DNA damage in biomonitoring studies.
Type of factor Description Examples Controlling the inﬂuence
Intrinsic (ﬁxed)
Non-modiﬁable Factor that is ﬁxed within each individual of the
study. Subjects do not control the factor
Age, sex, prescribed medication Can only be avoided by selection of
subjects or statistical adjustment
Modiﬁable Factor that de facto is ﬁxed within each
individual of the study. Subjects can change the
factor, but are not able or willing to do so
Tobacco smoke, occupational exposure, obesity,
over the counter drugs (“pain killers”)
Can only be avoided by selection of
subjects (i.e. occupational exposure) or
statistical adjustment
Extrinsic (random)
Non-modiﬁable Factor that is difﬁcult to avoid and may vary
over time. The subjects do not control the
source of agent, although they may control their
own exposure
Air pollution, ambient temperature, sunlight Can be avoided by sampling in short
periods and having equal sampling of
exposed and controls on the same days
Modiﬁable Factor that varies within each individual,
although it may ﬂuctuate little due to personal
habits. Subjects control the exposure
Diet, physical activity, alcohol consumption Can be avoided by adherence to strict
protocols (e.g. abstaining from
exhaustive physical activity)
A. Azqueta et al. / Mutation Research 783 (2020) 108288 5damage levels increase with age. Cross-sectional studies can
merely be used to show that subjects with different ages have
different levels of DNA damage. The review only includes results
from studies that have assessed levels of DNA damage in white
blood cells (WBCs), isolated as either leukocytes, peripheral blood
mononuclear cells (PBMCs) or lymphocytes.
2.2.1.1. Age. Studies published before 2000 have mainly shown
that age is not a strong predictor for the basal levels of DNA strand
breaks in WBCs, which may be due to the use of non-optimal comet
assay descriptors such as tail length [15]. A meta-analysis of
studies published up to 2005 has shown a positive association
between age and levels of DNA strand breaks in WBCs in studies
that had used %DNA in tail and visual classiﬁcation as comet assay
descriptors, whereas there was no difference in levels of
Endonuclease III (EndoIII)- and Formamidopyrimidine DNA
glycosylase (Fpg)-sensitive sites [16]. More recent studies, which
speciﬁcally have assessed age-differences in levels of DNA strand
breaks, have reported positive [17–23], null [24–28], or negative
associations [29]. The discrepancy between studies may be related
to multiple factors such as the age span, type of WBCs, analysis of
fresh or frozen sample and the statistical analysis. The latter
pertains to age treated as a categorical (i.e. age groups) or
continuous (i.e. true age in years) variable. In addition, multivariate
regression analysis seems to show little effect of age, which may be
due to control for confounding or mediator effects. For instance, a
large cross-sectional study of 992 subjects showed a positive
association between age and levels of DNA damage in PBMCs
(P < 0.05, linear regression, not reported in the original article), but
this was not signiﬁcant in analysis adjusted for sex and a number of
metabolic risk factors [28]. This indicates that the presumed effect
of age was mediated by various life-style factors.
Only a few studies have assessed associations between age and
oxidatively damaged DNA in WBCs. The reports have been mixed
with studies showing positive association [17,19,23] or no effect of
age on levels of damage assessed with the Fpg- or hOGG1-modiﬁed
comet assay [20,25,28,30]. Although mixed results have been
reported, age should be considered as a confounder in studies that
do not have statistical power to control for the effect of mediating
life-style factors.
2.2.1.2. Sex. A systematic review of the literature published up to
2005 did not show a difference between levels of DNA strand
breaks, EndoIII- and Fpg-sensitive sites in WBCs between women
and men [16]. This is in agreement with several more recent
studies that have shown no or equivocal difference between sexes
in studies using multivariate analysis [21,23,25,26,28,31–34]. Infact, only a few studies have shown sex-differences in multivariate
analysis; these reported a higher level of DNA strand breaks in
women [35] or a higher level in men [27]. Studies without
adjustment for potential confounders have either reported higher
levels of DNA strand breaks in men [36], higher levels in women
[24,32] or no effect of sex [37].
The relatively few studies on sex-dependent differences in
levels of DNA damage in the Fpg-, hOGG1-, or EndoIII-modiﬁed
comet assay have not revealed any difference between sexes
[28,31,32,36].
2.2.2. Intrinsic and modiﬁable factors
In theory, intrinsic and modiﬁable factors are changeable.
Examples of such factors are tobacco smoking, daily use of pain
killers and occupational exposures. Quitting smoking or changing
job is possible, but it is not likely to happen as part of a human
biomonitoring study. Thus, the effect of smoking or daily use of
pain killers is typically avoided by standard practices for control of
confounding. Likewise, exclusion of subjects from certain occu-
pations or job titles (e.g. blue collar workers) is possible in
molecular epidemiology.
2.2.2.1. Tobacco smoking. The effect of tobacco smoking on DNA
damage has been thoroughly studied since tobacco contains a great
variety of genotoxic/carcinogenic agents. Thus, smoking has also
been considered to be a confounding factor.
Kassie et al. published a review in which they found that
tobacco smoking causes an increase in DNA strand breaks in
several human studies; however, the extent of the damage did not
correlate with the number of cigarettes [38]. Some years later,
Faust et al. showed that only 9 reports, out of 29 studies, found that
tobacco smoking signiﬁcantly increases the DNA strand breaks in
lymphocytes, while 16 reports did not ﬁnd such an association
[39]. Moreover, the relationship between DNA damage and the
number of cigarettes smoked per day was still not clear; some
studies reported that smoking one or more cigarettes per day
produces DNA damage in comparison with non-smokers, while
others did not report any such effect even in those smoking 10 or
more cigarettes per day. In the same paper it was reported that
more than 55 % of the studies speciﬁcally carried out to study the
effect of tobacco smoking on DNA integrity using the comet assay
did not ﬁnd any association. Hoffmann et al. carried out a meta-
analysis of 38 published studies and found a higher level of DNA
strand breaks in smokers than in non-smokers [40]. However, the
effect was very small when smoking was investigated as a potential
confounding factor in occupational studies. In this direction,
Collins et al. stated that smoking does not appear to be an
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worth mentioning that the design of a study in which smoking is
considered just a confounding factor may not be powerful enough
to detect differences between smokers and non-smokers.
The discrepancies observed in the different studies can be due
to several factors such as the size of the sample (i.e. number of
participants), the number of cigarettes smoked and the period over
which they are smoked, the type of cigarettes (e.g. hand-rolled,
with or without ﬁlter) and the brand. It has been noted that reports
on the effect of smoking seemed to cluster in countries in the
southern part of Europe and it is possible that brands of cigarettes
with dark tobacco and high tar content are smoked more
frequently in that region [15]. Kocygita et al. showed that the
level of DNA strand breaks in mononuclear leukocytes were
signiﬁcantly higher in hand-rolled cigarette smokers than in ﬁlter-
cigarette smokers [42]. Both groups showed a signiﬁcantly higher
level of DNA strand breaks compared to the never smoker group.
Overall, smokers present, if anything, a slightly higher level of DNA
damage compared with non-smokers; but this cannot be detected
if the statistical power is weak [39].
Another factor that may contribute to the discrepancies
observed in different studies is passive smoking in the reference
group, which is normally overlooked [39]. In this respect, Lam et al.
carried out a study in elevator factory workers potentially exposed
to benzene and observed that tobacco smoking, both active and
passive at home, was signiﬁcantly associated with DNA damage
[43]. However, passive smoking in the work place did not affect
DNA damage.
In all these studies, the standard alkaline comet assay was used;
however, the Fpg-modiﬁed assay (or the use of another enzyme
detecting oxidized bases) can be more appropriate to detect the
DNA damage induced by tobacco smoking. Studies in which the
effect of tobacco smoking is assessed by using the enzyme-
modiﬁed comet assay to measure oxidized lesions are scarce.
Fracasso et al. showed a signiﬁcant high level of DNA strand breaks
in cells from active smokers compared with non-smokers or
passive smokers [44]. The DNA damage observed when using Fpg
was signiﬁcantly higher than the level of strand breaks detected
without using Fpg only in the group of active smokers. Surprisingly,
the authors did not check for differences in the net Fpg-sensitive
sites between groups. A review of 125 studies showed that
smoking did not inﬂuence the level of Fpg- and EndoIII-sensitive
sites [16]. It is worth mentioning that the objective of this study
was to look for reference values for DNA lesions in blood cells and
so not all the studies included smoking and non-smoking
participants for the detection of Fpg- and EndoIII-sensitive sites.
Smokeless tobacco (electronic cigarettes) is also a source of
genotoxic compounds. It should be emphasized that the effect of
smokeless tobacco has not been assessed inhumanexposurestudies.
However, it has been demonstrated that this form also induces DNA
strand breaks inperipheral blood samples [45]. Moreover, smokeless
tobacco induces a signiﬁcantly higher level of DNA strand breaks in
lymphocytes than does regular tobacco smoking [46].
2.2.2.2. Occupational exposure. The effect of occupational
exposure on DNA damage has been the subject of a large
number of studies for reasons such as workers' security and for
regulatory purposes, as well as for the investigation of biological,
physical and chemical occupational hazards.
A wide range of chemicals have mutagenic and/or carcinogenic
properties, that can act as environmental hazards, and may also be
exposure factors in speciﬁc occupational settings. For instance,
besides the risks to the general public, atmospheric pollution can
be considered as an occupational health hazard to professional
groups, such as trafﬁc police or professional drivers working in
urban areas [47,48].Biomonitoring of exposure to toxic chemicals in the workplace
is a fundamental tool to evaluate human health risks, and to
support strategies to establish a safe work environment. The comet
assay has been used to detect and quantify DNA damage as a
marker of exposure to genotoxic agents, in workers exposed to
various occupational hazards including gases, chemicals and
anticancer drugs. Its application in human safety and health risk
monitoring is well established, particularly when assessing
exposure to solvents, petrol by-products, heavy metals, mineral
ﬁbres and particulates. Several reviews summarize the wide-
ranging use of the comet assay in occupational biomonitoring
[39,41,49]. For instance, levels of Fpg-sites were signiﬁcantly
higher in WBCs and in buccal cells from “on the ground” airport
workers, compared with controls selected from ofﬁce workers at
the same airport [50]. A similar ﬁnding was reported in a study of
policeman in the Czech Republic [51]. Here, higher levels of both
oxidised purines and pyrimidines (Fpg- and EndoIII-sensitive sites)
were measured in policemen working outdoors and exposed to
trafﬁc emissions when compared with colleagues working indoors.
This effect was seasonal, and was only observed when air pollution,
measured as particulate matter and polycyclic aromatic hydro-
carbons (PAHs), was high. Oxidised DNA base damage correlated
positively with recorded levels of environmental carcinogenic
PAHs [51]. Genotoxic effects of occupational exposures to by-
products of petrol, heavy metals, organic solvents etc. have been
reviewed [47].
2.2.2.3. Body Mass Index (BMI). The association between
overweight/obesity (individuals with BMI  25 kg/m2) and DNA
strand breaks or oxidatively damaged DNA damage is well
documented [52]. In contrast, studies evaluating the inﬂuence of
BMI in a eutrophic population (BMI < 25 kg/m2) are scarce. Two
studies [53,54] have reported no correlation between normal BMI
(< 25 kg/m2) and DNA strand breaks. Thus, BMI within the normal
range does not appear to inﬂuence DNA damage in healthy
individuals.
2.2.3. Extrinsic and non-modiﬁable factors
Extrinsic and non-modiﬁable factors are characterized by being
ubiquitous and random exposures that are virtually impossible to
control in a molecular epidemiology study. Air pollution levels,
ambient temperature and sunlight are such factors that vary over
short (e.g. day-to-day) and long periods (e.g. seasons of the year). In
addition, they may display a high degree of co-variability. For
instance, high solar radiation correlates with temperature and
ozone levels. As sunlight exposure is highly dependent on the time
of the year, these exposures have typically been investigated in the
context of seasonal variation. Yet, air pollution is more complex as
it may correlate inversely with temperature in some parts of the
world (highest in the winter due to temperature inversion where
cold air is trapped at ground level) and positively in warm parts
(higher due to long-range dispersion of particles from wildland or
forest ﬁres).
2.2.3.1. Season. The impact of meteorology - and in a broader
sense seasonal variations - on the level of base-line DNA damage
measured via the comet assay, is studied in several papers. Topics
relating to seasonal changes include variation in temperature, solar
radiation (strength and duration), air pollution [ozone, particles,
(semi-)volatile compounds], diet (antioxidants, cooking
processes), allergy (pollen), physical exercise, time spent
outdoors/in the sun, and wearing less skin-covering clothes.
Recently, Geric et al. [33] reported that sampling season and
exposure to medical radiation were the two main variables in the
results of comet assay tests on whole blood of 162 inhabitants of
Zagreb (Croatia) recruited between 2008 and 2016. More
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radiation (J/cm2), temperature, and daily insolation (h), were of
inﬂuence. Their results conﬁrmed most earlier cross-sectional and
longitudinal studies. Increased DNA damage in warmer periods of
the year was indeed also reported in studies in which healthy
adults were sampled repetitively. In Greece, 40 non-smoking men,
engaged in outdoor activities for 6 h each day during the summer,
showed a higher level of DNA damage in mononuclear cells at the
end of the summer (September) compared to the end of the winter
(March) [55]. In Belgium, whole blood of 45 non-smoking ofﬁce
and laboratory workers was sampled four times, in all seasons of
one year [56], and another group of 48 non-smoking ofﬁce workers
were sampled in winter and again in summer [57]. In both studies,
DNA damage was correlated with the 8 -h-average ozone
concentrations and the average outdoor temperature in the
week before sampling. The latter studies were done to conﬁrm
the ﬁndings of a cross-sectional study in 200 adolescents (17-18y)
participating in the Flemish Environment and Health Survey. In
that study, both the whole blood comet assay results and urinary 8-
oxo-7,8-dihydro-20-deoxyguanosine (8-oxodG) were affected by
ozone concentrations and the average outdoor temperature, and
by the hours of sunshine 3 days before sample collection [58]. The
impact of solar radiation was intensively studied in another
longitudinal study by Møller et al. [35]. Twenty-one ofﬁce and
laboratory workers were followed up about once a month, during a
period of 14 months. DNA damage measured in the mononuclear
cells was correlated to the average daily inﬂux of sunlight during 3–
6 days before blood sampling. The results suggested that sunlight
penetrating the outer layer of the human epidermis (such as UVA
and UVB) damaged DNA in PBMCs circulating in the vessels of the
skin. Giovanelli et al. [25] observed in 79 ofﬁce and laboratory
workers sampled through the year a positive correlation of the
individuals' DNA damage in mononuclear cells with the outdoor air
temperature - and to a lesser extent with global solar radiation and
air ozone levels. The frequency of DNA strand breaks showed a
stronger seasonal trend as compared to the frequency of Fpg-sites,
being higher in summer. UV radiation induces oxidative stress, and
indeed speciﬁc photoproducts such as thymine dimers, that are
converted into transient strand breaks upon DNA repair [25].
Interestingly, subjects with higher BMI (BMI > 25 kg/m2) appeared
to have higher sensitivity to outdoor temperature variations,
perhaps because of a less efﬁcient heat dispersion [25].
On the other hand, it should be noted that also a few studies
reported DNA damage being higher in blood cells collected during
winter time, in polluted areas of e.g. Czech Republic [59] and
Poland [60]. Local heavier air pollution in the colder period,
characterized by temperature inversion and increased fossil fuel
burning, may explain this discrepancy.
Overall, higher sun radiation and outdoor temperatures seem to
be important factors in explaining the observed higher DNA
damage levels in warmer/sunnier seasons.
2.2.3.2. Environmental exposure. Anthropogenic pollution has
become inherent to the modern environment. The rapid global
increase in technogenic stress in the biosphere raises the question
about possible consequences for biota, including humans,
acknowledging that all forms of life are inter-connected and
that human health is strongly linked to the ecosystem’s health [61].
Environmental chemicals and contaminants are ubiquitous,
occurring in water, air, food and soil. While some chemicals are
short-lived in the environment and may elicit no harmful effects in
humans, other chemicals bio-accumulate or persist for a long time
in the environment or the human body due to frequent exposure,
potentially leading to adverse health effects [62]. Various studies
on comet assay endpoints in biomonitoring studies on
environmental exposures have been reviewed elsewhere [63].Among environmental exposures is air pollution, which is
ubiquitous and difﬁcult to assess without speciﬁc equipment,
although the relevant literature describes both personal exposures
as well as modelled data based on stationary monitoring station
recordings of ambient air pollution components. Air pollution,
primarily particulate matter from combustion processes, adversely
affects human health, increasing both mortality and morbidity. The
comet assay is being employed to establish the impact of air
pollutants on DNA damage in different population and occupa-
tional groups (reviewed in Møller and Loft [64]).
Temporal and spatial variations in air pollution levels are very
often used to obtain exposure gradients. In a study of people in
Benin either living/working near to persistently heavy trafﬁc, or in
a rural environment, Fpg-sensitive sites in PBMCs increased
according to location and personal exposure to benzene as a
speciﬁc component in fuel as indicated by urinary S-phenyl-
mercapturic acid (S-PMA), a biomarker of benzene exposure [65].
Examples of studies that have employed gradients in air pollution
levels come from studies in Denmark where personal exposure to
levels of ultraﬁne particles from trafﬁc correlated with levels of
Fpg-sensitive sites in PBMCs [66,67]. The same research group has
reported that trafﬁc-related air pollution in a chamber was
associated with higher levels of DNA damage in PBMCs [68],
whereas short-term exposure to even a high concentration of
diesel exhaust (276 mg/m3 for 3 h) had no effect on DNA strand
breaks or oxidatively damaged DNA in PBMCs [69]. Wood smoke is
another important source of particulate matter, which is increas-
ingly relevant as an environmental exposure with the increasing
number of wildﬁres. Nevertheless, recent studies have shown
mixed results - in chamber studies after short-term exposure
[70,71], or a one-week stay in a reconstructed Viking Age house
with an indoor open ﬁre [72], or in wildﬁre ﬁreﬁghters [73].
Likewise, a recent chamber study showed that 5.5 h exposure to
household dust (275 mg/m3) did not alter levels of DNA strand
breaks or oxidatively generated purine lesions in PBMCs [74]. The
collective results indicate that trafﬁc-related air pollution has a
greater effect on the types of DNA lesions that are detected by the
comet assay, compared with either wood smoke or dusts in
household air. Also, gases such as carbon monoxide, ozone,
nitrogen oxides, sulphur dioxide are examples of atmospheric
pollutants that may lead to DNA damage and pose a serious threat
to human health. Other applications of the comet assay regarding
air pollution include exposure to formaldehyde and nitrogen
dioxide in children living near a chipboard factory in Italy [75],
PAHs in the air in children in Mexico [76], and pollution containing
cadmium, lead, dichlorodiphenyldichloroethylene (p,p'-DDE),
hexachlorobenzene, polychlorinated biphenyls (PCBs) and ben-
zene in residents in Flanders [77].
2.2.4. Extrinsic and modiﬁable factors
In daily life people are in contact with many agents with the
potential to provoke or prevent mutagenic and carcinogenic effects
[78]. In comparison with intrinsic and non-modiﬁable factors such
as age and sex, these exposures are not constant as they may
display day-to-day variation and may be avoided (e.g. by subjects
disliking the taste of dietary items) or actively sought for personal
reasons (e.g. regular physical activity). Such factors might not
cause confounding in a study as they may be highly individualized.
For instance, ingestion of certain dietary items may be associated
with genotoxicity, but there are few subjects with the relevant
dietary habit in the source population. Thus, in the rare event of
such a person entering a biomonitoring study, the biomarker value
is likely to be regarded as an outlier.
2.2.4.1. Dietary exposure to toxic substances. There are relatively
few studies that have assessed the inﬂuence of dietary genotoxic
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from a biomonitoring study on aﬂatoxin exposure in the Gambia
[79]. However, genotoxic effects of food mutagens have been
investigated in cell cultures or animal models. An interesting
example of a hybrid approach is a study where the comet assay was
used to examine the negative inﬂuence of foods such as red meat,
using cultured human colon cells exposed to human faecal waters
[80].
2.2.4.2. Dietary macro-and micro-components. The comet assay is
used extensively in human biomonitoring to assess the impact of
whole foods (e.g. fruits and vegetables), speciﬁc nutrients
(phytophenols and antioxidants) and supplements (e.g. folic
acid, selenium, carotenoids) on biomarkers of DNA stability,
including DNA strand breakage, and altered DNA bases (e.g.
oxidation, alkylation and misincorporated uracil).
The ability of whole foods to protect against DNA damage has
been tested extensively using the comet assay in observational
studies. Historically, a high intake of various foodstuffs, such as
fruits, vegetables and juices, that are rich in antioxidant vitamins
and phytophenols, has been found to be positively associated with
low levels of endogenous DNA strand breakage and oxidised DNA
bases, and to protect against ex vivo generation of DNA damage
(reviewed in Dusinska and Collins [81]). A recent cross-sectional
study focused on habitual ingestion of ﬁsh, vegetables, fruits,
salads, whole-grain bread and potatoes in a relatively large study of
subjects (n = 973) in a high-income area of Copenhagen, Denmark
[82]. This showed an inverse association between intake of ﬁsh and
levels of Fpg-sensitive sites in women after adjustment for various
other life-style factors. The same inverse association was also seen
in univariate analysis in men, but it was not robust in adjusted
analysis, whereas salad intake was inversely associated with levels
of Fpg-sensitive sites in adjusted analysis. Although this is merely a
cross-sectional study, it points especially to the intake of ﬁsh as a
food category that may have a protective effect on levels of
oxidatively damaged DNA in humans. It is an observation that
needs to be conﬁrmed in a well-designed intervention trial.
Diet and dietary components have been shown to play an
important role in the protection against DNA damage in well-
designed intervention studies. The comet assay is used widely to
investigate the inﬂuence of intervention with speciﬁc nutrients
(primarily as supplements) and whole foods on biomarkers of
genomic stability, including DNA strand breakage and base
damage. In a ground-breaking study testing the antioxidant
hypothesis of DNA damage and cancer, supplementing male
smokers and non-smokers with vitamin C (100 mg), vitamin E
(280 mg) and β-carotene (25 mg) daily for 20 weeks, substantially
decreased endogenous DNA pyrimidine oxidation (measured using
EndoIII) and signiﬁcantly increased resistance to hydrogen-
peroxide-induced DNA strand breakage ex vivo [83].
Several medium- to long-term intervention studies have shown
reduced levels of DNA lesions after ingestion of bioactive-rich
foods and/or food bioactives [84–89]. However, the protective
effects have also been detected after the intake of single portions of
bioactive-rich foods and/or components [90–93]. This modulation
seems to be dependent on several factors such as the type of food
product(s), the bioavailability of the constituent(s) and the length
of time between food consumption and DNA damage evaluation.
There have been few studies evaluating the acute effect of
bioactive-rich foods on the levels of oxidized purines and
background DNA strand breaks, with conﬂicting results. Bakuradze
and co-workers [94] found that the intake of 200 mL of coffee,
every 2 h until 8 h, signiﬁcantly decreased background DNA strand
breaks levels in healthy volunteers. Brivida et al. [95] showed that
the consumption of 1000 g of organically or conventionally grown
apples, providing 308 and 321 mg/g fresh weight of totalpolyphenols respectively, decreased the levels of EndoIII-sensitive
sites at 24 h after consumption. In contrast, Del Bo’ and colleagues
[91,96] reported no signiﬁcant effect on DNA strand break levels
and Fpg-sensitive sites following acute consumption of blueberries
in smoking and non-smoking volunteers.
Folate deﬁciency very speciﬁcally results in the misincorpora-
tion of the RNA-associated base uracil into DNA, consequently
inducing DNA single and double strand breakage and chromosom-
al damage [97]. One modiﬁcation of the comet assay has allowed
uracil explicitly to be measured in human lymphocyte DNA [98].
Here, nucleoids, post-lysis, are incubated with the bacterial DNA
repair enzyme uracil DNA glycosylase, revealing misincorporated
uracil in the DNA. In a randomised double-blind placebo-
controlled intervention, mis-incorporated uracil, measured using
the alkaline comet assay and uracil DNA glycosylase, was
signiﬁcantly decreased in healthy men and women supplemented
with 1.2 mg folic acid each day for 3 months [99]. Moreover, it was
also found that improved folate status (red cell, lymphocyte and
plasma folate) strongly correlated with the reduction in DNA uracil
mis-incorporation, highlighting the value of this modiﬁed comet
assay in human biomonitoring [99].
A special application of the comet assay in dietary intervention
studies has been the challenge assay where the resistance to ex vivo
induced DNA damage by an oxidizing agent such as H2O2 has been
measured. Protection has been reported following either an
antioxidant cocktail of β-carotene, vitamin C and vitamin E [83]
or more complex food sources such as carrot juice [100], tomato
extract [101], kiwi fruits [102,103], broccoli [104,105], wild
blueberry [106] and hazelnuts [107]. However, some studies
reported no effect [108–110].
On the whole, bioactives should be recognized as potential
confounding factors (see 2.2.3). This could represent a critical
aspect within biomonitoring studies in which the evaluation of
DNA damage by the comet assay is performed in different subjects
exposed to diverse conditions. On the other hand, evidence is very
scarce or non-existent concerning the impact on DNA damage of
the consumption of meals differing in macro and micronutrients or
the impact of supplements and their possible antagonistic and/or
synergistic effects. The dietary intervention studies have been
instrumental for research on speciﬁc macro- or micronutrients.
However, they also tend to be somewhat excessive in the exposure.
For instance, it will be difﬁcult to ﬁnd a person who daily eats 300 g
blueberry purée or drinks 500 mL of kiwifruit juice [91,93]. The
results from the dietary intervention studies may not be directly
applicable for biomonitoring guidelines. In that respect, it should
be emphasized that certain intervention studies have selected
speciﬁc groups of the population to avoid confounding, and the
sampling of cells has been optimized to detect the effect on DNA
damage levels. Generalization of the observations from dietary
intervention studies to the general population is uncertain.
Conservatively, it is recommended that the evaluation of DNA
damage is performed on samples of blood that have been collected
on a standardized time schedule (e.g. after an overnight fast). Such
standardization of factors related to diet and overall behaviour
could help to minimize potential bias and improve the comparison
of data deriving from different studies.
2.2.4.3. Physical activity. The comet assay has been used to
investigate the potential induction of DNA damage after physical
exercise since it is known that this practice causes oxidative stress
[111]. DNA instability has been assessed in two different scenarios;
in volunteers just after performing exhaustive physical activity or
in volunteers who regularly perform physical activity.
Hartmann et al. tested the effect of a short run with increasing
speed in 3 healthy volunteers and found an increase in DNA strand
breaks in WBCs after the exercise [112]. The effect was seen after
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were back to basal level after 72 h. In the same study volunteers
were subjected to a 45 min run at ﬁxed speed to ensure aerobic
metabolism, and the aforementioned effect was not seen [112]. The
same authors demonstrated how vitamin E supplements de-
creased the DNA damage detected after 24 h of running on a
treadmill until exhaustion [113]. They also showed that although
trained and untrained volunteers exhibit a signiﬁcant increase in
the DNA damage of WBCs after exhaustive exercise, the increase
was higher in untrained than in trained volunteers, suggesting an
adaptation process [114]. Some years later, the same group
performed a study in which they measured DNA damage in 6
athletes after a short-distance triathlon competition [115]. No
effect was seen after the exercise; however a signiﬁcant increase in
DNA strand breaks was seen after 1–5 days in a biphasic pattern,
with a small peak after 24 h and a larger one after 3 days. After 5
days, the basal level was not reached. However, the Fpg-modiﬁed
comet assay did not reveal any extra damage. Likewise, there were
unaltered levels of Fpg-sensitive sites and DNA strand breaks after
a triathlon race, whereas the levels of EndoIII-sensitive sites were
slightly increased at day 5 post-exercise [116]. A shorter bout of
exhaustive bicycle exercise also did not change the levels of DNA
strand breaks, Fpg-sensitive sites and EndoIII-sensitive site when
performed in normoxia, whereas there were increased levels of
DNA strand breaks immediately after exercise in high altitude
hypoxia [117]. The increase in DNA damage after a bout of exercise
has also been seen in forty older adults and in young soccer players
after performing physical activity [118,119]. The young soccer
players did not recover the basal DNA damage level even after 45
days [11]. Esteves et al. showed how the level of DNA oxidation
damage in dancers, measured using Fpg, signiﬁcantly increased
after the dancing season [120]. However, the pre-season level was
lower than in a control group. In this case, the levels of DNA strand
breaks were not signiﬁcantly affected.
The effect of regular exercise on the basal level of DNA damage
in volunteers who exercise regularly has also been tested. While
some authors report a lower level of DNA damage in lymphocytes
of people who perform regular exercise [19,120–122], others did
not ﬁnd any association between exercise and the level of DNA
damage [37,123] and some even report a higher level [124]. In this
last study, even the H2O2 resistance was lower in sportsmen doing
regular exercise, namely rugby players. In a recent study, the DNA
damage level found in lymphocytes was lower in the recreational
group compared to sedentary and lifelong amateur endurance
practice volunteers [125].
To sum up it is quite clear that DNA damage increases after a
bout of exhaustive exercise but the effect is not so clear in people
who regularly take part in sport. An adaptive response was
proposed in the case of low levels of DNA damage found in
sportsmen [114].
2.2.4.4. Alcohol consumption. Acetaldehyde, the ﬁrst metabolite in
alcohol degradation, induces crosslinks and forms adducts with
DNA and proteins [126,127]. There are several human studies in
which the effect of alcohol consumption on the DNA damage has
been studied using the comet assay.
Studies performed in alcoholics showed that they present
higher levels of DNA damage in blood cells than do control subjects
[128,129]. A positive correlation between alcohol intake and DNA
damage has also been found in healthy individuals [27,130]. In
contrast, Pool-Zobel and co-workers showed that DNA damage in
rectal cells and lymphocytes, both DNA strand breaks and EndoIII-
sensitive sites, was lower in male patients with alcohol abuse than
in controls [131]. However, the number of participants, especially
of the controls, was very low. Løhr et al. showed a signiﬁcant
positive association between alcohol intake and Fpg-sensitive sitesin men but not in women [28]. The study was performed in 1019
subjects (aged 18–93) with the aim of studying the association of
the levels of oxidatively damaged DNA and metabolic risk factors.
Milic et al. did not ﬁnd any increase in DNA damage in blood cells of
alcohol consumers compared to non-consumers [132].
Alcohol consumption has been included as co-variate in the
statistical analysis (i.e. as a possible confounder) in several studies,
showing conﬂicting results. Some studies have reported a positive
association between alcohol consumptions and DNA damage in
blood cells [133,134]. A lack of association between DNA damage in
blood cells and alcohol consumption has been reported by several
authors [135–139]. Moreover, the lack of association has also been
reported in exfoliated buccal cells [140].
Conﬂicting results can be due to the amount or the type of
alcohol consumed; many of the reports do not give this
information. Also, the sample size can have a great impact on
the reliability of results. Moderate alcohol consumption, especially
wine drinking could also have beneﬁcial effects on redox status
and DNA stability. It has been hypothesized that regular
consumption of moderate doses of wine could provide health
beneﬁts. Wine's beneﬁcial effect has been attributed principally to
its non-alcoholic portion, which has antioxidant properties [141–
143]. An important issue to mention is that acetaldehyde induces
DNA crosslinks, which can indeed decrease DNA migration. This is
a factor to take into account when interpreting results, and could
be a cause of conﬂicting results.
3. Sample type and collection
Sample collection is an important step and variability needs to
be reduced as much as possible in order to obtain reliable data.
Each laboratory should set up standard collection procedures and
adhere strictly to them throughout the experiments.
In particular, it is necessary to deﬁne the following during the
planning phase: subject conditions at collection time (e.g. fasted or
not for blood samples, timing during the day if relevant, etc.);
collection modality; choice of anticoagulant for blood, cell
maintenance medium for all cells, enzymatic treatment where
required; temperature and maximal extent of bench time (from
sample collection to comet slide preparation); container and tube
types; sample identiﬁcation and documentation.
3.1. Blood and blood-derived samples
3.1.1. Blood collection and anticoagulant
Blood is obviously the most suitable and widely used tissue in
human biomonitoring, due both to the low invasiveness of the
withdrawal and to the abundance of information available on
blood composition deriving from routine clinical biochemistry. The
majority of studies use venepuncture but blood collection with a
lancet could also be suitable as only a small volume of blood is
necessary and mean baseline levels of damage from pin-prick
samples and samples collected by venepuncture have been
described to be similar [144].
The choice of anticoagulant may be crucial, as an increase in
plasma DNA (from damaged leukocytes) has been reported to
occur beyond 6 h in samples collected with citrate or heparin [145].
However, whether the choice of anticoagulant has any effect on
comet assay results has not been established, and EDTA, citrate and
heparin are all currently used.
3.1.2. Different blood-derived preparations and cell types
Among blood cells, the most used so far are gradient-isolated
mononuclear leukocytes, often referred to as “lymphocytes”,
although in this fraction monocytes are also present in a signiﬁcant
proportion (about 1/4 of the mononuclear fraction). The reason to
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homogeneous than total leukocytes, is that PBMCs circulate
throughout the body, have a reasonably long life span, and can
therefore serve as sentinel cells in biomonitoring studies [146].
However, it has been shown that the procedure of PBMC isolation is
not devoid of consequences on the basal levels of DNA damage:
strand breaks are increased in gradient-isolated PBMCs compared
to non-isolated, although oxidized bases measured as Fpg-
sensitive sites are not modiﬁed [147]. Bausinger and Speit reported
that radiation- and alkylating agent-induced DNA damage is
decreased in PBMCs compared to whole blood [148]. The response
to ex vivo oxidative stress is also much higher in PBMCs than in
whole blood [147]. This is actually an advantage of the isolated
cells, especially in intervention studies where antioxidant/protec-
tive treatments are tested. In fact, the basal levels of DNA damage
in blood cells are usually very low in healthy volunteers, and it
would be difﬁcult to measure a further decrease of these levels;
instead, it is possible in this context to evaluate the protection from
ex vivo-induced DNA damage, reﬂecting the antioxidant status
[91,93].
An increasing number of human biomonitoring studies with the
comet assay have used whole blood, thus avoiding the separation
procedure [149–151]. In this case only nucleated cells, i.e. the
leukocytes can be studied. Using whole blood is simpler, but since
it contains the complete spectrum of leukocytes, results obtained
with whole blood and with isolated PBMCs may not be
comparable. The possibility has been described to score separately
polymorphonuclear and mononuclear cells in whole blood slides,
but the procedure is time consuming, and the visual distinction can
be subjected to variability originating from both different
operators and different employed assay conditions [147].
In biobanks (see section 5.3 Long-term storage of frozen
samples), blood is usually stored either as such or as buffy coat,
and the possibility to work with these samples can give access to
large epidemiological retrospective studies. For this reason, buffy
coat has recently received attention from researchers interested
in the use of the comet assay in human biomonitoring. The
preparation of the buffy coat involves a simple centrifugation of
whole blood, producing a layer enriched in concentrated
leukocytes at the top of the red cells) that can consequently be
aspirated in a small volume. In the end, a blood preparation with
5–6 times concentrated leukocytes is obtained, in which the
WBCs still beneﬁt from the protective effects of plasma and red
blood cell antioxidant power. Indeed, unpublished studies
indicate that the basal levels of DNA damage measured in buffy
coat preparations are not different from those measured in whole
blood, supporting the hypothesis that this preparation can be
equally useful. An advantage of buffy coat compared to whole
blood is that it is often available in biobanks [152]. Still, it needs to
be veriﬁed whether the presence of free radical-producing
neutrophils can modify the basal levels of damage with time,
particularly upon long-term storage, given the presence of
protective red blood cells [153].
Although most of the studies use leukocytes from whole blood,
there is increasing interest in assessing primary DNA damage in
salivary leukocytes especially in terms of air pollution impact.
These cells, directly exposed to air passage through the mouth,
represent the target cells of this exposure and in that way are more
appropriate than blood cells for the evaluation of its effects.
Moreover, they are easy to retrieve, especially in children, using a
simple and non-invasive method, which allows obtaining a
substantial sample size. Despite that, some problems have been
identiﬁed, such as the number of cells retrieved per sample, the
interference caused by the buccal epithelial cells on the comet
images, and the consequent time-consuming analysis of the slides
[154–156].3.2. Epithelial cells
Epithelial cells amenable for human biomonitoring are
exfoliated cells from easily-reached epithelia, such as those in
mouth and nose, which are also ﬁrst-contact sites for environ-
mental pollutants. Cell collection might be relatively easy, but the
number of cells obtained is usually quite low, although this is
generally not a problem with the comet assay, which can be run
with very small numbers of cells. Another important issue with
exfoliated cells is their physiological state (dead, necrotic/
apoptotic, damaged or healthy) that can inﬂuence the measured
levels of DNA damage: thus, the assessment of cell viability appears
to be particularly important before proceeding to the measure-
ment of DNA damage. Furthermore, in some cases there might be a
need to separate cell aggregates through enzymatic digestion. For
all these reasons, usually these cells display higher basal DNA
damage levels than blood or cultured cells: however, it has been
shown that it is still possible to detect increases in DNA damage in
association with different environmental stressors. Sampling
protocols, sample storage and preparation for the most used cell
types, and the adaptations of the method for each speciﬁc context,
have been reviewed by Rojas et al. [157].
The use of exfoliated buccal cells has been proposed and
repeatedly used for genotoxicity testing in human biomonitoring
both with the micronucleus test and with the comet assay [158].
These cells can be simply obtained by mouth wash or oral mucosa
brushing. Increases in DNA damage in these cells have been reported
in occupational settings [159], and in association with lifestyle and
environmental factors such as tobacco smoking, pollutants in
drinking water [160], or radiations [161]. It has also been proposed
that these cells can be a useful tool in nutritional studies [158].
Nasal cells are obtained by gently brushing the turbinate
epithelium [162,163]. This cell type has an obvious advantage over
circulating leukocytes in studies on inhalation exposure to
airborne pollutants in the ambient air or workplace. In some
cases of air pollution exposure, the results obtained in nasal cells
were different from those obtained in peripheral leukocytes,
indicating that these epithelial cells can be a better marker of
damage, at least for some types of exposure or pathology [164].
Although this type of cell is very relevant for respiratory exposure,
the brushing procedure, although minimally invasive, is reported
to be unpleasant for the donor, and probably for this reason it has
not gained as much popularity as it might have.
Tear duct epithelial cells are also exposed to environmental
pollutants, and can be simply recovered from tears. Up to date, only
one study has used them in human biomonitoring [165], ﬁnding a
DNA-damaging effect of urban atmospheres with high ozone
concentrations.
An interesting new application of the comet assay involves cells
from surgically removed tissues from the human eye, including
corneal epithelium and endothelium, lens capsule, iris and retinal
pigment epithelium [166]. This cell type is interesting due to the
direct contact of airborne DNA damaging agents with the epithelial
cells of the eye, although the technique needs to be further
developed and validated.
Exfoliated bladder cells can be recovered from urine and used
for routine urine cytology, and they have also been used for DNA
damage measurement with the comet assay. In rubber workers at
risk of bladder cancer, comet assay results showed a better
concordance with cytoscopy than with urine cytology [167].
3.3. Biopsies
The comet assay is routinely used to detect DNA damage on
tissue samples in genotoxicology studies. In fact, the OECD
guideline for the in vivo comet assay (TG 489) refers speciﬁcally
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application of the comet assay is rarely used in research projects on
healthy humans. A rare example is the use of the comet assay,
including the enzyme-modiﬁed comet assay, on muscle biopsies
from healthy human volunteers who were exposed to high altitude
hypoxia [169]. In clinical contexts, cells from biopsies, such as
colon biopsies have also been used [131].
4. Sample collection timing
Sampling conditions such as sampling time can be an important
factor in the comet assay because DNA damage can increase, if
environmental conditions are not optimal. It is suggested that
seasonal variations and sampling time play a more important role
in the comet assay than in other cytogenetic assays such as
micronuclei and chromosomal aberrations [170]. In biomonitoring
studies, it is advisable to take blood samples at the same time from
fasting subjects (usually in the morning hours) and to transport
them in cool conditions. However, it is more important to collect
samples from all exposed and control subjects at the same time of
the day to reduce the possibility of time variations that can
inﬂuence the results [171]. If a study extends over more than a year,
samples should be taken in the same season in each year. When
blood was sampled in the warmer period of the year, comet assay
descriptors were found to be higher [33,81].
5. Sample processing and storage
5.1. Bench time
Ideally, the comet assay is performed immediately following
peripheral blood collection. However, in large human studies or
studies requiring sampling far from laboratories, these optimal
conditions are not feasible. In this context, storage conditions of
whole blood should be optimised before performing the comet
assay. It can also be a good strategy to cryopreserve samples in
studies with repeated sampling from the same subjects such as
dietary interventions or environmental exposures (e.g. air pollu-
tion). The reason is that the exposure contrast may produce less
response (i.e. delta-value between exposure and control period)
than the inter-day assay variation.
In some cases, samples can be processed within several hours,
and the comet assay is performed on fresh cells. Koppen et al.
reported a weak decline of DNA strand breaks with increasing
storage time on the bench, for samples processed within 6 h of
sampling. Turbulence and shearing during blood drawing might
have induced mechanical damage upon sampling, being restored
during the time after collection [172]. The same was also described
by Dusinska and Collins [81] in PBMCs processed within 4 h after
sampling. On the other hand, in both studies, an increase in Fpg-
sensitive sites was observed when blood samples were stored at
room temperature during those time periods.
Anderson et al. reported that storage for up to 4 days at either
room temperature or 4 C did not induce any DNA strand breaks in
human whole blood measured with the comet assay [173]. Similar
conclusions that samples can be stored for up to 4 days at both
room temperature and 4 C without affecting the level of DNA
strand breaks were found in the study from Collins [174]. Chang
and Hu have also shown that DNA strand breakage in whole blood
was stable up to 4 h at 4 C after isolation [175]. In contrast, the
study from Narayanan et al. described an increase in DNA damage
when human blood was stored at room temperature or 4 C for
24 h, with a further increase after 48 h of storage [176]. More
recently, Al-Salmani and co-workers also reported that overnight
storage (12 h) of a large volume of blood (5 mL) at 4 C tended to
induce an increase of damage [144].The temperature, volume and duration of blood storage appear
to be crucial parameters to consider when processing samples for
the comet assay. Altogether, these studies suggest that some
components of whole blood can be considered as preservative
agents but these effects are limited, and temperature, volume and
time dependent. Moreover, some components and reactions can
also alter the DNA, e.g. lysis of red blood cells and presence of
neutrophils that can undergo an oxidative burst.
Due to inconsistent results from all these studies, short time
storage (less than 4 h), at 4 C or room temperature is advised in
order to avoid any DNA damage between whole blood collection
and processing for the comet assay.
5.2. Effect of transport
Shipping of whole blood, kept in an isolated package, to keep
the blood at room temperature (ca. 1535 C) is a feasible option
based on the results of Anderson et al. [173] and Koppen et al. [172].
They showed that whole blood samples stored at room tempera-
ture up to respectively 4 and 3 days, did not show an increase in
DNA strand breaks.
5.3. Long-term storage of frozen samples
Storage of samples represents a common practice in biomo-
nitoring studies where, for logistic reasons, the comet assay is not
generally performed on fresh material. In fact, the majority of
human data on DNA damage are derived from analyses performed
on cryopreserved cells, but in some cases, there is no mention of
the storage process (e.g. method of cryopreservation, duration of
storage). Both whole blood and isolated PBMCs can be frozen and
stored at 80 C or in liquid nitrogen. However, the freezing
method, the medium used for cryopreservation, storage conditions
and the thawing process, could all represent potential critical
factors affecting cell viability, DNA damage levels, and cellular
responses (such as DNA repair). At the moment, there are various
approaches to sample cryopreservation. For whole blood, some
researchers suggest ﬂash-freezing small volumes (max250 mL) of
samples in order to avoid crystal formation [144]; others report
that diluting whole blood with an equal volume of cell culture
medium containing 20 % DMSO prevents damage during freezing
[177]. Regarding PBMCs, some studies suggest suspending cells in
PBS or medium with 10 % DMSO [41], while others report
suspending cells in 50 % foetal bovine serum, 40 % medium and 10
% DMSO [13]. The number of cells stored could be an important
factor to be standardized. For example, to improve cell viability it is
recommended to freeze PBMCs at concentrations of 3  107 cells/
mL [178]. For optimal cryoprotection of PBMCs, slow freezing is
recommended (ideally 1 C/min) using a commercial’ Mr Frosty’
freezing unit with isopropyl alcohol, or a well-insulated expanded
polystyrene box.
A different approach was used by Zhang et al. where DNA was
successfully preserved in freeze-dried somatic cells using trehalose
as protectant and storage at or below 4 C [179]. Furthermore, solid
tissues for later comet assay analysis are typically stored via snap
freezing in liquid nitrogen, keeping the tissue deep-frozen until they
are rapidly homogenized and embedded in agarose [180].
Regarding the effect of long-term storage on DNA damage, the
information available is limited and insufﬁcient to exclude the
existence of a signiﬁcant impact. Several studies have reported an
increase in DNA damage with the freeze-thaw process compared
with that found in different fresh cells [181–183], while others
reported no effect on the levels of DNA damage [144,184,185].
These conﬂicting results could be attributed to the time and
storage temperature of cryopreservation used. For example, Del Bo’
et al. documented an increase in the levels of background DNA
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80 C compared with fresh samples [186]. In contrast, Duthie and
co-workers showed that the levels of oxidized pyrimidines,
oxidized purines and uracil were similar in both freshly isolated
and frozen lymphocytes [185], implying that the DNA damage that
is already present in the DNA of fresh cells is maintained
throughout the isolation and storage procedure. However, the
samples were stored only for 2 months. Pu and colleagues showed
that the storage of lymphocytes at 80 C up to 28 days did not
affect the DNA damage, while the storage at 20 C for 14 and 28
days increased both DNA strand breaks and oxidatively damaged
DNA compared to fresh cells [181]. Regarding the use of whole
blood, the same authors found no signiﬁcant changes in samples
stored at 20 C for 1 day or 7 days, or at 80 C for up to 28 days
compared to fresh samples, while they documented signiﬁcant
increases in both DNA strand breaks and DNA base oxidation in
whole blood samples stored at 20 C for 14 or 28 days [181]. Akor-
Dewu and colleagues showed that freezing whole blood at 80 C
is a suitable method for storing samples, at least for periods of a
few weeks or months, for subsequent analysis of DNA strand
breaks and Fpg-sensitive sites [184]. However, the ability of H2O2
to induce DNA strand breaks is severely attenuated in whole blood
compared with freshly isolated or frozen PBMCs. Leukocytes
isolated from frozen blood showed higher basal levels of damage
(strand breaks/alkali-labile sites) and an abnormal resistance to
damage by H2O2 compared to PBMCs isolated from fresh blood
[184], though after repeated washing (to remove residual
erythrocyte components) their sensitivity to H2O2 resembled that
of PBMCs.
The ultimate in long-term storage is the biobank. Biobanks are
repositories storing biosamples, in 80 C freezers or in or above
liquid nitrogen, generally for research and/or clinical purposes.
They represent a potentially valuable resource for DNA damage
analysis, but only if appropriate freezing and storage conditions
have been followed. Cryopreservation protocols are available for
PBMCs [185,187,188] as well as whole blood [144,152,172].
Protocols and try-outs for preservation of DNA in buffy coat
samples were recently tested [152,153,189].
Assuming an appropriate preservation method was used, any
type of sample from a biobank can be used for assessment of DNA
damage using the comet assay. European biobanks can be
identiﬁed through the biobank directory of the European Research
Infrastructure Consortium: Biobanking and BioMolecular resour-
ces Research Infrastructure (BBMRI-ERIC) (http://www.bbmri-eric.
eu/). The platform describes the nature, origin, destination, and the
biobank lifecycle of each biospecimen (time of collection, pre-
registration, receipt, processing, quality control, storage condi-
tions, request for use, retrieval, and distribution). Experience with
the comet assay on samples stored for extended periods is limited,
and careful evaluation of results will be needed, at least until
optimal conditions for cryopreservation and for reducing adverse
effects of storage have been deﬁned.
6. Statistical analysis
Due to the epidemiological nature of biomonitoring studies, a
critical evaluation of statistical methods for the analysis of comet
assay results should take into consideration the study design and
the control of external variables. Therefore, critical issues include a
proper estimation of the sample size, the detection and control of
bias during study design, and strategies to control for confounding
and to search for effect modiﬁcation. As a matter of fact, the
question to be answered by a biomonitoring study is not if an effect
of the condition under evaluation is present or not (p value), but
how large is this effect (relative to the unexposed controls), and
how reliable is this estimate (conﬁdence interval).6.1. Statistical considerations
The comet assay used in biomonitoring studies shares some
basic features with other biomarkers used for the measurement of
early pathogenetic events, such as high technical variability and
poor agreement between scorers, the departure from normality,
the need to deﬁne a ﬁxed number of cells to be scored, etc. On the
other hand, this biomarker is characterized by a number of peculiar
features. For example, several endpoints can be evaluated for the
same physical outcome (i.e. migration of DNA in the agarose gel).
Even when statistical analyses include only the four most
frequently used endpoints (i.e. tail intensity, tail length, tail
moment and damage index), a problem of multiple comparison
may originate in many cases, because more than one endpoint is
often measured in the same study.
The possible approaches for design and analysis of experimen-
tal studies using the comet assay have been described in several
papers [190]. Much less literature is available for the use of this
biomarker in biomonitoring studies. A critical evaluation of the
most used statistical approaches has been published by Collins
et al. [41]. The most common statistical procedures entailed
univariate parametric and non-parametric techniques, while
regression analysis was carried out in nearly one third of the 50
studies reviewed. Standard approaches used in epidemiologic
studies, such as controlling of confounding and testing for
interaction, were seldom applied. The use of the p-value to
compare study groups was common, while quantitative measures
of effect (point and interval) were used occasionally.
To describe the endpoints of the comet assay, measures of
central tendency are commonly computed, usually the arithmetic
mean and the median. This is generally reasonable when the
sample size is large and the frequency distribution is unimodal or
not markedly asymmetric. In this case, for descriptive purposes
only, reporting arithmetic mean and standard deviation is correct.
However, if these conditions are violated, the range of minimum/
maximum values and some signiﬁcant percentiles, for instance 25-
th, 50-th (median) and 75-th, should be used instead, as they are
less sensitive to the above-mentioned violations [191].
With appropriate transformations, it is possible to approximate
the distribution ofvarious endpointsof the comet assay tothe normal
distribution,which exhibits important statistical properties. In many
cases it is suitable to use the original value logarithm to improve the
distribution normality [192]. Whenever the data distribution does
not differ from a normal distribution, the levels of DNA damage can
be compared between two groups by applying the Student’s t-test.
When the analysis is aimed at comparing three or more exposure
groups, a natural extension of the t-test is the analysis of variance
(ANOVA) [192]. When the sample size is small, and/or log-
transformation does not work, a non-parametric approach is
preferred. The Mann-Whitney test is an efﬁcient non-parametric
approach to compare two unpaired groups. If the data are paired or
matched, then the Wilcoxon matched pairs test provides a valid
alternative to the paired Student’s t-test. The Kruskal-Wallis test can
be applied as a non-parametric alternative to the ANOVA.
In observational investigations of human populations, individ-
uals may differ in several conditions, including lifestyle, exposure
to occupational and environmental toxic agents, or genomic
proﬁle. If the distribution of conditions affecting DNA damage is
unbalanced in the study groups, the association under study can be
confounded by the action of these factors. Effect modiﬁcation is
another important feature, since it identiﬁes subpopulations that
respond differentially to the condition under study. While the
confounding effect of external variables can be taken into account
in the statistical analysis of data, the presence of effect modiﬁca-
tion can be merely identiﬁed and separate analyses for relevant
subpopulations should be performed. The most straightforward,
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effect modiﬁcation is statistical modelling [41,191]. With the use of
statistical modelling it is possible to quantify the presence of a
relationship between the outcome and all considered variables
(categorical or continuous) to generate estimates of association
adjusted for the effect of confounders, and to assess the presence of
effect modiﬁcation. In the ﬁeld of biomarkers, most statistical
models are ﬁtted to data to assess whether a variable predicts an
outcome, and they are generally known as regression models [193].
In general, to build up regression model, it is necessary to deﬁne
the way through which the linear predictor (LP) acts on the mean
response (m), and to identify a probability distribution for the
response variable (Y), essential to estimate the parameters
included in the regression equation using the maximum likelihood
(ML) method. An extensive discussion on the probability distribu-
tion of data from biomonitoring studies using the comet assay can
be found in Lovell and Omori [190], conﬁrming that in most cases a
normal or a log normal distribution can be assumed.
In its simplest form, that is the multiple normal (additive)
regression, the coefﬁcient of regression expresses the variation of
m per each unit increase of each linear predictor when the other
predictors are held constant. The effect of the variables analysed on
the level of DNA damage is measured in the same unit as the
outcome, e.g. mm for the tail length or % for tail intensity. This
feature may be misleading in the presence of a large interlabor-
atory variability since, for example, an increase of 2 mm in tail
length may be a small variation in some laboratories while in
others it may represent an important change. The shift to log
transformed data to approximate the normal distribution, implies
two important modelling characteristics, i.e. expected values (m)
are non-negative (due to the antilog function), and measures of
effect are ratios (multiplicative scale) and not differences (additive
scale). Thus, as is shown in the following equation, the measure of
the association between exposure and outcome is represented by
the ratio of expected mean values (MR) of exposed (E = 1) to
unexposed (E = 0) individuals, once confounding is removed:
log mE¼1ð Þ  log mE¼0ð Þ ¼ log
mE¼1
mE¼0
 
¼ b1 !
mE¼1
mE¼0
¼ eb1 ¼ MR
Recently, traditional approaches to statistical analysis of data
from biomonitoring studies have been implemented with advanced
techniques, in many cases derived from the analysis of clinical trials.
For instance, multicentre biomonitoring studies may exhibit a
hierarchical structure with multiple levels: if several laboratories are
involved in different areas, individual DNA damage levels represent
the ﬁrst level of the hierarchy, while laboratories and areas represent
the following levels. This type of data organization implicitly
assumes that each level is nested in the higher level and represents a
homogeneous cluster of observations. The purpose of the multilevel
regression modelling [194] is to verify whether the hierarchical
structure affects the measurements of interest. Ignoring the
multilevel structure of data means that an important component
of within-cluster correlation may be missed, underestimating the
standard errors of the parameters evaluated. In this framework, two
classes of regression parameters can be estimated using the
multilevel regression. The ﬁrst class is represented by the ﬁxed
effects parameters (β) which return the mean effect of covariates
(exposure in particular) within or across levels. The second class are
deﬁned as the random effects (REs) parameters and reﬂect the degree
of heterogeneity within each level.
6.2. Number of subjects and statistical power
Sample size evaluation is a preliminary step of study design.
The study population size should be large enough to reachstatistical signiﬁcance if the observed effect (i.e. level of DNA
damage in exposed vs. unexposed subjects) is as large as expected
or even larger. Since the level of statistical power and the chance of
the type 1 error are quite standardized, i.e. 80 % and α < 0.05, the
deﬁnition of the sample size is essentially based on the magnitude
and the variability of the expected effect [191]. Under mild
statistical conditions (normality and homoscedastic data assump-
tion), sample size calculation can be derived from the following
formula [192]:
N > 2 S
za þ zb
d
 2
where:
 zα and zβ are the standardized normal deviates corresponding to
α and β error rates [e.g. 1.96 (corresponding to zα = 5 %) and 0.84
(corresponding to zβ = 80 %)];
 d ¼ y1  y0is the anticipated difference in mean DNA damage
between exposed and unexposed subjects respectively;
 S = standard deviation obtained from pilot studies or from the
literature;
 N is the number of subjects in each group.
There are several user-friendly statistical packages available in
the internet for the optimal sample size calculation. The presence
of several possible endpoints, a peculiarity of the comet assay, is
not a major concern, since all of them follow approximately a
normal distribution (even if within a ﬁxed interval, in the case of
the damage index).
The choice of the reference value is a little more complicated.
This value is the mean DNA damage that would be observed in the
study population if the study factor were not present. Given the
large inter-laboratory variability of the assay results, it may be
unreliable to use reference values from studies performed in other
laboratories or from the literature. It seems advisable to use data
from previous studies conducted in the same laboratory, or even
better from a pilot study performed using the same conditions as in
the ﬁnal study.
In some cases, it may be difﬁcult to have a reliable estimate of
the standard error, and the equation could be resolved for the ratio
of the anticipated mean difference between exposed and unex-
posed to its variability (d / S). Obviously, the study size will grow
larger as the expected difference between the means of unexposed
and exposed individuals is smaller or its variability is larger.
7. Ethical issues
Ethical issues regarding biomonitoring studies conducted with
the comet assay are not different from ethics requirements typical
of other molecular epidemiology studies, because the reasons that
justify conducting biomonitoring studies with this assay are
similar to those for using other tests. The debate on ethical issues in
molecular epidemiological research dates from the beginning of
this discipline [195]. Often these studies do not provide direct and
immediate beneﬁts to participants; however, they may have
scientiﬁc and public interest, as long as they can measure the
effects of an intervention or improve our knowledge of occupa-
tional or environmental risks, allowing the implementation of
preventive measures.
A desirable, distinctive feature of the comet assay is the
possibility of using a variety of non-invasive procedures for
biosample collection, which supports a highly favourable balance
between health beneﬁts and risks and involves minimal interfer-
ence with the participants. Sampling methods, nature and quantity
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particularly when dealing with vulnerable populations [196,197].
Guidelines exist about sample collection and biorepository
management, and they generally include substantive chapters on
ethical issues (e.g. [198–200], inspired by the principles of the
Declaration of Helsinki [201]). These guidelines are constantly
updated and modiﬁed, as the scientiﬁc and social debate
progresses, while technical evolution poses new ethical and legal
questions and challenges. In addition, ethical and data protection
rules may vary greatly across laboratories and countries, an aspect
that should be attentively considered when planning multicentric
studies and international collaborations [198]. The need for a more
harmonized and consistent socio-ethical and legal approach in
human biomonitoring studies has been pinpointed some time ago,
at least at the European level, with the aim of guaranteeing more
equality in the protection of individual rights and increasing data
comparability [202]. The European Cooperation in Science and
Technology (COST) is a funding organization for research networks
– called COST Actions. The network on human biomonitoring using
the comet assay (hCOMET) strives to improve the quality of the
technique in studies on human exposures and diseases. Prepara-
tion of speciﬁc guidelines with Standard Operating Procedures for
human biomonitoring studies with the comet assay is one of the
goals of hCOMET. The guidelines will cover all major aspects of
planning and execution of this kind of research, including ethical
issues (http://www.hcomet.org).
Ethical issues are governed by law in most countries. A study
cannot start before submission to the concerned ethics committee
(EC) at an institutional, regional or national level for “consider-
ation, comment, guidance and approval” [201]. The committee
must be transparent, independent and qualiﬁed.
The ECs generally include experts from several ﬁelds (e.g.
lawyers, statisticians, toxicologists, psychologists) and evaluate the
study design, sample collection procedures, questionnaires and
informed consent documents. In addition, insurance arrangements
may be required when the specimen collection can pose a risk to
the participants (e.g. blood samples), and many countries also
require clearance from the agencies which oversee data safety
[203].
Informed consent has a central role for the respect of autonomy.
It must be obtained before collecting any biological sample or
clinical, social and occupational data from the subjects participat-
ing in the study. Comprehensible information must be given to all
participants on the nature and implications of the study, on
potential risks, discomforts and beneﬁts for them. It must be
clearly stated that they enter voluntarily in the study and they have
the right to withdraw with no consequence at any moment.
Incentives or compensations, when permitted by local law, must be
described in detail. Particular attention must be paid when
vulnerable subjects are concerned, as is the case of adults with
intellectual disabilities or children [196].
Future studies are being mentioned with increasing frequency in
the informed consent forms, due to the rapid technological
progress in sample analysis, the diffusion of large biorepositories,
the drive towards analyses of pooled data and the spread of
epidemiological study designs such as historical cohorts and
nested case-control studies. Maximizing the amount of informa-
tion which is obtainable from limited samples, while minimizing
the burden imposed to participants is per se an ethical issue, and
allows saving of time and resources. Data sharing and material
transfer represent a major asset of modern molecular epidemiolo-
gy; however they need to be governed by speciﬁc transfer
agreements. The subjects should have the possibility to agree or
not, freely and consciously, to the use of their biological data for
future study questions and by other researchers in unforeseeable,
unspeciﬁed assays or follow up studies [203].Protection of privacy and conﬁdentiality of data stored or
processed for research purposes is the object of increasing
attention by the regulatory bodies. Any biological material should
be coded, and the identities of subjects participating in the study
should be protected in databases through safe coding, encrypting
or anonymizing procedures. Proper data management must be
secured, and speciﬁc databases, not available to outsiders, may be
used for storage of their personal data [200]. However, a strictly
anonymous collection of samples may be almost useless for
molecular epidemiological research, which is based on linkage of
laboratory results with other personal data of the subjects (e.g.
occupation, health-related conditions, lifestyle, genetic proﬁle,
clinical follow up [204]).
Finally, each subject has the right to decide whether to be
informed or not of the results of the study, and this should be
explicitly mentioned in the informed consent form. In human
biomonitoring studies communication is preferably given at group
level: information on individual risk might generate stress or
stigmatization, and in any case the ability of the comet assay to
assess individual risk is still far from being clear, when
extrapolated from the research context. The development of a
communication plan is recommended and may be of great help,
particularly in case of reporting of unexpected results with
unknown clinical signiﬁcance [205].
8. Strengths, weaknesses and limitations of the comet assay in
human biomonitoring
As a biomarker assay in human studies, the comet assay has
these advantages:
- - It can be applied to blood samples, which are obtained in a
relatively non-invasive way; it is assumed that blood cells,
circulating throughout the body, reﬂect the overall body
burden of DNA damage;
- It is simple and economical to perform;
- It can be performed on samples stored frozen (though whether
there is a limit on the period of storage needs to be
established);
- It requires only a small number of cells (though for
measurement of DNA repair, more material is needed);
- There is no need to stimulate the cells to divide;
- Other tissues can be used under certain circumstances (for
example, tissue obtained after surgery for cancer);
- The measurement of oxidation damage to DNA using enzymes
(i.e. Fpg or EndoIII) is relevant not just to cancer but to other
diseases involving oxidative stress, whether as a cause or an
effect.
There are some disadvantages and limitations:
- Circulating WBCs are not 'target' cells for carcinogenesis in solid
tissues;
- Preparation of single cells is needed in the case of solid tissues,
which may increase the background level of DNA damage;
- The assay shows rather high levels of variability, especially when
comparing results between laboratories;
- Some forms of damage are not detected with the comet assay
(bulky adducts), or cannot be distinguished (double- and single-
strand breaks), or require complicated modiﬁcations (inter-
strand cross-links);
- DNA damage measured in human cells is a marker of exposure to
damaging agents, but there is no evidence as yet that it can be
used as a predictive marker of cancer risk;
- The assay is saturated (i.e. the % tail DNA approaches 100) at a
level of damage of a few thousand lesions per cell, and so its
A. Azqueta et al. / Mutation Research 783 (2020) 108288 15detection range is less than that of other assays. However, this
range easily covers physiologically relevant levels of damage
(levels that human cells can survive).
- Results with Fpg should be interpreted with caution; Fpg detects
some alkylated as well as oxidised bases.
- The EndoIII-modiﬁed comet assay does not have an assay
control, which implies that the results on this type of DNA
damage are somewhat uncertain. Efforts should be made to
develop a reliable positive assay control for the EndoIII-modiﬁed
comet assay.
9. Application and interpretation of comet assay results in
human biomonitoring studies
The comet assay is often used in biomonitoring studies on
environmental, occupational and dietary exposures as a biomarker
of exposure to genotoxic agents (or protective agents in the case of
phytochemicals). This includes cross-sectional, panel (i.e. repeated
sampling from the same subjects) and controlled exposures
studies (e.g. intervention trials). Considering the diversity of study
designs, it is not meaningful to list speciﬁc recommendations for
enhancing the application and interpretation of comet assay
results, although certain issues are noteworthy. The study design,
way of controlling confounding factors, collection of samples and
the choice of statistical analysis must be assessed on a case-by-case
basis. Using one type of study design will affect the way
confounding can be controlled and the choice of statistical
analysis. As a biomarker of exposure to genotoxic agents, there
are certain considerations relevant to users of the comet assay:
- Dealing with confounders is a challenging effort. A “one size ﬁts
all” solution does not exist as there are different ways to deal
with confounders, depending on the sample population. It
should also be stressed that control for confounding is not a “the
more the merrier” situation. Very strong control of confounding
might introduce attenuation bias due to over-matching of
exposed and unexposed subjects. At present there is not
concrete knowledge on which factors are consistent and strong
determinants for the level of DNA damage and which have just
been associated with DNA damage in certain studies. There is
relatively large inter-study variation in the effect of potential
confounders as well as environmental, occupational and dietary
exposures. The inter-laboratory variation may be due to
differences in sampling of cells, comet assay procedures (i.e.
differences in baseline levels of DNA damage), populations (i.e.
susceptibility to DNA damage by the exposure), and control for
confounding factors in the study design or statistical analysis. It
is important to note that control for presumed confounders by
restriction might yield results that cannot be generalized. For
instance, if the presumed confounder is actually an effect
modiﬁer, there will be inter-study variation in the effect of the
exposure between two studies that have assessed the associa-
tion in the different strata of the general population.
- The sample collection depends on feasibilities and economic
issues (e.g. it may only be possible to sample at one time point,
which may have been selected to analyse other biomarkers with
narrower window of effect). Likewise, the effect of cryopreser-
vation and differences in DNA damage between subpopulations
of leukocytes are issues that would be easy to standardize (e.g.
by recommending the use of cryopreserved PBMCs), but would
require adoption by all researchers.
- The proper statistical analysis is determined by the study design
and control for confounding or effect modiﬁers. General
recommendations on the statistical analysis cannot be made
in the same way as for instance studies on animals or cells.However, biomonitoring studies are rarely so simple that
Student’s t-test, Mann-Whitney U test or simple correlation
tests are appropriate statistical methods.
- The use of internal assay controls is crucial in biomonitoring
studies. Assay controls should always be analysed in studies that
use samples directly in the comet assay without cryopreserva-
tion because they provide information about the assay variation
over time. In principle, it is not necessary to include assay
control in controlled exposure studies on cryopreserved
samples if they are analysed in the same comet assay run;
but it increases the validity of the study and in the enzyme-
modiﬁed comet assay it provides important information about
the activity of the enzyme. However, it is important to note that
inclusion of assay controls does not reduce the inter-laboratory
variation in basal levels of DNA damage or differences in
susceptibility due to effect modiﬁers.
10. Further development needs
This review has revealed many aspects of the comet assay
where further development is necessary or desirable. Variability
between laboratories would be greatly reduced if a standard
protocol were adhered to; with this in mind, standard operating
procedures are being devised within the hCOMET COST Action. The
use of reference standards - i.e. cells with a known amount of DNA
damage - should be mandatory in biomonitoring studies, serving
two purposes; ﬁrst, as an internal laboratory check on the
performance of the comet assay on the day, and second, to
facilitate comparisons between laboratories ('normalising' all data
so that they are expressed as functions of the reference standard
value). Ideally, reference standards could be provided by a central
laboratory. There is a strong case for calibrating the assay (using X-
or gamma-irradiated cells, since the frequency of breaks induced
per Gy is known), so that all results could be expressed in terms of
breaks per 109 Da, or per 106 base-pairs, for example.
While modiﬁcations of the comet assay to measure altered DNA
bases (oxidised purines, oxidised pyrimidines, and uracil) are now
used routinely to assess the impact of occupational and
environmental exposures on genomic stability, new variations
are being developed to further improve the speciﬁcity and
effectiveness of the assay in human biomonitoring. A modiﬁed
comet assay using speciﬁc restriction endonucleases (HpaII, HhaI
and MspI) has been developed with the aim of measuring the
global methylation status of DNA in single human cells [206,207].
Aberrant DNA methylation, both hypo- and hyper-methylation, is
strongly linked with carcinogenesis in vivo and in humans.
Adapting the comet assay to speciﬁcally detect changes in DNA
methylation patterns in human subjects will undoubtedly advance
understanding of how epigenetics inﬂuences human cancer risk.
DNA repair is an important facet of individual response to DNA
damage effects, whether it is intrinsically determined, or inducible
by exposure. As a biomonitoring tool it is somewhat neglected, as
techniques for measuring it are laborious and/or require large
numbers of cells. A miniaturized version of the DNA repair assay
using a smaller number of cells would be very useful.
The question of whether DNA damage can be a predictive
marker of cancer risk will only be answered by a prospective or
retrospective trial, in which DNA damage is measured in a large
number of healthy subjects who are subsequently monitored over
many years for the occurrence of disease or death. The possibility
of using stored blood or buffy coat samples from existing
prospective studies should be explored.
There is an ongoing debate over the best method for short- and
long-term storage of human blood and isolated blood cells. Many of
us were surprised by the ﬁnding that small volumes of blood could
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routinely used to preserve larger volumes [144,184]. Validated
standard procedures would be very useful. There is also a need for
further comparative study of the kinds and levels of damage in
different blood cell fractions, and the correlation (or otherwise)
between them.
As described above, disparate results have been reported
concerning effects on DNA damage levels of smoking, various
exposures, season of sampling, age, sex etc. In an attempt to resolve
these issues, a pooled analysis of data from a large number of
studies (involving almost 20,000 individual subjects) is being
undertaken by hCOMET. Using a database this large, it may be
possible to rank the effect of potential confounders and thus
distinguish important confounders from those that have had little
or inconsistent effect on DNA damage levels measured with the
comet assay.
11. Final considerations
The comet assay for DNA damage and repair is now very well
established as a biomonitoring tool, in various contexts: in cross-
sectional studies, prospective cohort studies, case-control studies,
and intervention trials. It has been applied to studies of
occupational and environmental exposure, nutrition, disease risk,
or simply used to investigate comparative levels of DNA damage/
repair in different groups (for instance men, women and children,
or different age groups, or vegetarians and omnivores). It is
perhaps surprising that it is used successfully in spite of the
excessive inter-laboratory variability that has been demonstrated
in various ring studies; it would certainly be reassuring if this
variability could be reduced or eliminated. It is probably too much
to expect that laboratories will adopt a standard procedure, but an
appreciation of which experimental variables are crucially impor-
tant and which do not matter would help. It should be mandatory
to include reference standards, and to report in publications the
critical experimental variables. The use of appropriate statistical
methods in analysing comet assay data is essential, but to date this
has too often been neglected. It should be clear that a well-
performed comet assay experiment (i.e. with high technical skills
in the laboratory) may be wasted if little attention has been paid to
epidemiological principles including proper study design and
statistical analysis. Simple statistical tests such as the Student’s t-
test or the Mann-Whitney U test are applicable in biomonitoring
studies on binary exposures categories if there is adequate control
of confounders. However, the situation is typically complex as
most exposures and co-variates are continuous variables and even
controlled exposure studies (e.g. intervention trials) may have
subjects dropping out of the study or loss of samples. This “loss to
follow-up” may lead to disproportionate distribution of con-
founders in exposure groups. Statistical planning to ameliorate the
impact of such events should be considered as a good investment
for biomonitoring studies using the comet assay.
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